236 related articles for article (PubMed ID: 6680403)
1. View from the Nation's Capital.
Romansky MA
J Clin Psychopharmacol; 1983 Feb; 3(1):47-8. PubMed ID: 6680403
[No Abstract] [Full Text] [Related]
2. View from the Nation's Capitol.
Freishtat HW
J Clin Psychopharmacol; 1982 Jun; 2(3):219-20. PubMed ID: 6927305
[No Abstract] [Full Text] [Related]
3. View from the Nation's Capital.
Romansky MA
J Clin Psychopharmacol; 1984 Jun; 4(3):161-2. PubMed ID: 6096408
[No Abstract] [Full Text] [Related]
4. View from the Nation's Capital.
Freishtat HW
J Clin Psychopharmacol; 1985 Apr; 5(2):117-9. PubMed ID: 3988970
[No Abstract] [Full Text] [Related]
5. View from the Nation's Capital.
Romansky MA
J Clin Psychopharmacol; 1983 Oct; 3(5):319-21. PubMed ID: 6680407
[No Abstract] [Full Text] [Related]
6. View from the Nation's Capitol.
Freishtat HW
J Clin Psychopharmacol; 1982 Apr; 2(2):146-8. PubMed ID: 6926924
[No Abstract] [Full Text] [Related]
7. View from the Nation's Capital.
Romansky MA
J Clin Psychopharmacol; 1984 Feb; 4(1):52-4. PubMed ID: 6096407
[No Abstract] [Full Text] [Related]
8. View from the nation's capital.
Romansky MA
J Clin Psychopharmacol; 1985 Feb; 5(1):51-2. PubMed ID: 2982923
[No Abstract] [Full Text] [Related]
9. View from the Nation's Capital.
Appler WD
J Clin Psychopharmacol; 1986 Feb; 6(1):42-4. PubMed ID: 3950066
[No Abstract] [Full Text] [Related]
10. Experimental use and the Orphan Drug Act: a biotechnology conundrum.
Koivuniemi PJ
Nat Biotechnol; 1996 Apr; 14(4):511-2. PubMed ID: 9630930
[No Abstract] [Full Text] [Related]
11. View from the Nation's Capital.
Romansky MA
J Clin Psychopharmacol; 1984 Oct; 4(5):288-9. PubMed ID: 6096409
[No Abstract] [Full Text] [Related]
12. View from the Nation's Capital. FDA challenged successfully on its policies regarding good manufacturing practice inspections of medical drug and device manufacturers.
Appler WD
J Clin Psychopharmacol; 1987 Oct; 7(5):346-7. PubMed ID: 3680606
[No Abstract] [Full Text] [Related]
13. Incentives for drug development--the curious case of colchicine.
Kesselheim AS; Solomon DH
N Engl J Med; 2010 Jun; 362(22):2045-7. PubMed ID: 20393164
[No Abstract] [Full Text] [Related]
14. View from the Nation's Capital: the Orphan Drug Act--prospects and problems.
Romansky MA
J Clin Psychopharmacol; 1984 Aug; 4(4):230-2. PubMed ID: 6470200
[No Abstract] [Full Text] [Related]
15. Orphan Drug Act.
Van Woert MH
Prog Clin Biol Res; 1985; 197():7-9. PubMed ID: 4070300
[No Abstract] [Full Text] [Related]
16. Should the patent system for new medicines be abolished?
DiMasi JA; Grabowski HG
Clin Pharmacol Ther; 2007 Nov; 82(5):488-90. PubMed ID: 17952100
[No Abstract] [Full Text] [Related]
17. View from the Nation's Capitol.
Romansky MA
J Clin Psychopharmacol; 1982 Feb; 2(1):74-5. PubMed ID: 6926923
[No Abstract] [Full Text] [Related]
18. Pediatric testing of prescription drugs: the Food and Drug Administration's carrot and stick for the pharmaceutical industry.
Karst KR
Am Univ Law Rev; 2000; 49():739-72. PubMed ID: 11067732
[No Abstract] [Full Text] [Related]
19. Drug development and patent law.
Nusbaum NJ
N Y State J Med; 1992 Mar; 92(3):86-7. PubMed ID: 1557205
[No Abstract] [Full Text] [Related]
20. Should off-label drug use be off-the-table?
Rivkees SA
J Pediatr Endocrinol Metab; 2007 Feb; 20(2):171-2. PubMed ID: 17396432
[No Abstract] [Full Text] [Related]
[Next] [New Search]